Your browser doesn't support javascript.
loading
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Gemici, Aliihsan; Ozkalemkas, Fahir; Dogu, Mehmet Hilmi; Tekinalp, Atakan; Alacacioglu, Inci; Guney, Tekin; Ince, Idris; Geduk, Ayfer; Cagliyan, Gulsum Akgun; Maral, Senem; Serin, Istemi; Gunduz, Eren; Karakus, Volkan; Bekoz, Huseyin Saffet; Eren, Rafet; Pinar, Ibrahim Ethem; Gunes, Ahmet Kursad; Sargin, Fatma Deniz; Sevindik, Omur Gokmen.
Afiliación
  • Gemici A; Department of Hematology, Medipol University, Istanbul, Turkey. Electronic address: inci.alacaciogl@deu.edu.tr.
  • Ozkalemkas F; Department of Hematology, Uludag University, Bursa, Turkey.
  • Dogu MH; Department of Hematology, Istinye University, Istanbul, Turkey.
  • Tekinalp A; Department of Hematology, Necmettin Erbakan University, Konya, Turkey.
  • Alacacioglu I; Department of Hematology, Dokuz Eylul University, Izmir, Turkey.
  • Guney T; Department of Hematology, University of Medical Sciences, Ankara City Hospital, Ankara, Turkey.
  • Ince I; Division of Hematology, Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey.
  • Geduk A; Department of Hematology, Kocaeli University, Kocaeli, Turkey.
  • Cagliyan GA; Department of Hematology, Pamukkale University, Denizli, Turkey.
  • Maral S; Division of Hematology, Diskapi Training and Research Hospital, Ankara, Turkey.
  • Serin I; Division of Hematology, Istanbul Training and Research Hospital, Istanbul, Turkey.
  • Gunduz E; Department of Hematology, Osman Gazi University, Eskisehir, Turkey.
  • Karakus V; Department of Hematology, Alaaddin Keykubat University, Alanya, Turkey.
  • Bekoz HS; Department of Hematology, Medipol University, Istanbul, Turkey.
  • Eren R; Division of Hematology, Bozyaka Training and Research Hospital, Izmir, Turkey.
  • Pinar IE; Department of Hematology, Uludag University, Bursa, Turkey.
  • Gunes AK; Department of Hematology, University of Medical Sciences, Ankara City Hospital, Ankara, Turkey.
  • Sargin FD; Department of Hematology, Medipol University, Istanbul, Turkey.
  • Sevindik OG; Department of Hematology, Medipol University, Istanbul, Turkey.
Clin Lymphoma Myeloma Leuk ; 21(8): e686-e692, 2021 08.
Article en En | MEDLINE | ID: mdl-34059487
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Compuestos Bicíclicos Heterocíclicos con Puentes / Antineoplásicos Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Compuestos Bicíclicos Heterocíclicos con Puentes / Antineoplásicos Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article